Lauren Boudreaux, DO
Dermatology · Vancouver, WANPI 1003235706
Payments from drug & device makers
Across 641 payments — averaging $24.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- UCB, Inc.$2K
- LEO Pharma Inc.$2K
- Johnson & Johnson$2K
- Novartis$1K
- Galderma Laboratories, L.p.$536
- plus $3K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 166 | $4,550 |
| UCB, Inc. | 15 | $2,235 |
| LEO Pharma Inc. | 19 | $2,186 |
| Johnson & Johnson | 112 | $1,804 |
| Novartis | 140 | $1,318 |
| Galderma Laboratories, L.p. | 39 | $536 |
| Regeneron Healthcare Solutions, Inc. | 22 | $432 |
| E.r. Squibb & Sons, L.L.C. | 14 | $335 |
| Sanofi | 17 | $308 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 18 | $215 |
| Amgen | 10 | $189 |
| Merz North America, Inc. | 2 | $182 |
| Arcutis Biotherapeutics, Inc. | 6 | $181 |
| Incyte Corporation | 9 | $174 |
| Organon | 10 | $162 |
| Lilly USA, LLC | 10 | $162 |
| Pfizer | 10 | $158 |
| Sun Pharmaceutical Industries Inc. | 5 | $97 |
| Biofrontera Inc. | 5 | $57 |
| Dermavant Sciences, Inc. | 2 | $42 |
| Biowound Solutions, Inc. | 2 | $33 |
| Strata Skin Sciences, Inc. | 2 | $26 |
| VYNE Pharmaceuticals Inc. | 1 | $25 |
| Bristol Myers Squibb | 1 | $22 |
| Revance Therapeutics, Inc. | 1 | $18 |
| Fresenius Kabi USA, LLC | 1 | $15 |
| Celltrion USA Inc. | 1 | $13 |
| Dermira, Inc. | 1 | $12 |
How this compares
$15,484 in reported general payments places this provider in the 90th percentile of 323 dermatology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Vancouver
- Viet NguyenVancouver$11K
- Joel DatloffVancouver$6K
- William WerschlerSpokane$5.1M
- Clive LiuBellevue$3.3M
- Katherine ReedSpokane$3.1M
- Morrisa BaskinWenatchee$1.1M
- Vivian ShiSeattle$1.1M
- Daniel LevyBonney Lake$541K
- Daniel SugaiBellevue$302K
- Michi ShinoharaSeattle$277K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.